The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
105972914 10597291 4 F 20141022 20160830 20141121 20160902 EXP AU-ROCHE-1479807 ROCHE 74.37 YR F Y 79.00000 KG 20160902 MD AU AU

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
105972914 10597291 1 PS Pertuzumab PERTUZUMAB 1 Intravenous (not otherwise specified) LOADING DOSE Y H0030B18,1133409 125409 840 MG SOLUTION FOR INFUSION
105972914 10597291 2 SS Pertuzumab PERTUZUMAB 1 Intravenous (not otherwise specified) LAST DOSE PRIOR TO SAE 08/OCT/2014?MAINTENANCE DOSE Y H0030B18,1133409 125409 420 MG SOLUTION FOR INFUSION Q3W
105972914 10597291 3 SS Trastuzumab TRASTUZUMAB 1 Subcutaneous LAST DOSE PRIOR TO SAE 08/OCT/2014 Y 1133409,1146333 103792 600 MG SOLUTION FOR INJECTION Q3W
105972914 10597291 4 SS NAB-PACLITAXEL PACLITAXEL 1 Intravenous (not otherwise specified) LAST DOSE PRIOR TO SAE 22/OCT/2014 Y 0 180 MG SOLUTION FOR INFUSION /wk
105972914 10597291 5 C LORATADINE. LORATADINE 1 Unknown 0
105972914 10597291 6 C PANADEINE FORTE ACETAMINOPHENCODEINE PHOSPHATE 1 Unknown 0
105972914 10597291 7 C OXYCONTIN OXYCODONE HYDROCHLORIDE 1 Unknown 0
105972914 10597291 8 C ENDONE OXYCODONE HYDROCHLORIDE 1 Unknown 0
105972914 10597291 9 C SLOW K POTASSIUM CHLORIDE 1 Oral 0 2 DF TABLET
105972914 10597291 10 C COLOXYL WITH SENNA DOCUSATESENNOSIDES 1 Oral 0 4 DF TABLET
105972914 10597291 11 C PARACETAMOL ACETAMINOPHEN 1 Unknown 0
105972914 10597291 12 C MAGMIN MAGNESIUM ASPARTATE 1 Oral 0 4 DF TABLET
105972914 10597291 13 C CALTRATE CALCIUM CARBONATE 1 Oral 0 TABLET
105972914 10597291 14 C CALTRATE CALCIUM CARBONATE 1 Unknown 0
105972914 10597291 15 C CHOLECALCIFEROL CHOLECALCIFEROL 1 Unknown 0 70 UG
105972914 10597291 16 C LASIX FUROSEMIDE 1 Unknown 20-40 MG 0
105972914 10597291 17 C CLEXANE ENOXAPARIN SODIUM 1 Unknown 0 20 MG

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
105972914 10597291 1 HER-2 positive breast cancer
105972914 10597291 3 HER-2 positive breast cancer
105972914 10597291 4 HER-2 positive breast cancer

Outcome of event

Event ID CASEID OUTC COD
105972914 10597291 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
105972914 10597291 Dermatitis bullous
105972914 10597291 Vomiting

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
105972914 10597291 1 20140716 20140716 0
105972914 10597291 2 20140806 20141113 0
105972914 10597291 3 20140717 20141112 0
105972914 10597291 4 20140717 20141027 0
105972914 10597291 5 20140731 0
105972914 10597291 6 20140731 0
105972914 10597291 7 20141008 0
105972914 10597291 8 20141008 0
105972914 10597291 9 20141025 0
105972914 10597291 10 20141025 0
105972914 10597291 11 20141026 0
105972914 10597291 12 20141028 0
105972914 10597291 13 20141029 0
105972914 10597291 14 20141210 20141212 0
105972914 10597291 15 20141029 0
105972914 10597291 16 20141008 0
105972914 10597291 17 20141210 20141212 0